文献速递中枢神经肿瘤放疗放疗物理与技术

胶质母细胞瘤同步放化疗6周疗程中肿瘤动态的预测因素及其对生存的影响

Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-03-30

这项前瞻性纵向影像观察研究纳入129例胶质母细胞瘤患者,在放疗计划时、第10次、第20次分次及放疗后1个月行磁共振成像,评估肿瘤体积相对变化与迁移距离。结果显示胼胝体受累和手术切除程度是肿瘤动态的独立预测因素,第10次分次肿瘤增大及放疗后1个月迁移与更差生存相关。

要点

  • 胼胝体未受累者第20次分次肿瘤体积相对变化较受累者显著降低(P = .03)。
  • 全切除者第10次和第20次分次肿瘤体积相对变化较活检和次全切除者显著降低(P = .001)。
  • 第10次分次肿瘤体积相对变化≥1.33与更差总生存相关(HR 4.6,95%CI 1.8-11.4,P = .001)。

核心结论

  • 胼胝体受累和手术切除程度是放疗期间肿瘤动态的独立预测因素,可用于筛选适合自适应放疗策略的患者。
  • 第10次分次肿瘤显著增大和放疗后1个月肿瘤迁移与更差总生存相关。

研究设计与样本

  • 胶质母细胞瘤纵向影像观察研究的前瞻性系列磁共振成像研究,纳入129例胶质母细胞瘤患者。
  • 在放疗计划时(F0)、第10次分次(F10)、第20次分次(F20)和放疗后1个月行磁共振成像。

主要发现

  • F10时肿瘤体积相对F0的中位相对体积为0.85(范围0.25-2.29),F20为0.79(范围0.09-2.22),放疗结束后1个月为0.78(范围0.13-4.27)。
  • F10时中位迁移距离为4.7 mm(范围1.1-20.4 mm),F20为4.7 mm(范围0.8-20.7 mm),放疗结束后1个月为6.1 mm(范围0.0-45.5 mm)。
  • 与胼胝体受累患者(n = 26)相比,胼胝体未受累患者(n = 103)F20时肿瘤体积相对变化显著降低(P = .03),F20时迁移距离更小(P = .007)。
  • 与仅活检(n = 19)和次全切除(n = 71)患者相比,全切除患者(n = 38)F10(P = .001)和F20(P = .001)时肿瘤体积相对变化显著降低,F10(P = .03)和F20(P = .002)时迁移距离更小。
  • O6-甲基鸟嘌呤-DNA-甲基转移酶甲基化和异柠檬酸脱氢酶突变状态与肿瘤动态无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We present the final analyses of tumor dynamics and their prognostic significance during a 6-week course of concurrent chemoradiotherapy for glioblastoma in the Glioblastoma Longitudinal Imaging Observational study. METHODS AND MATERIALS: This is a prospective serial magnetic resonance imaging study in 129 patients with glioblastoma who had magnetic resonance imaging obtained at radiation therapy (RT) planning (F0), fraction 10 (F10), fraction 20 (F20), and 1-month post-RT. Tumor dynamics assessed included gross tumor volume relative to F0 (Vrel) and tumor migration distance (dmigration). Covariables evaluated included: corpus callosum involvement, extent of surgery, O6-methylguanine-DNA-methyltransferase methylation, and isocitrate dehydrogenase mutation status. RESULTS: The median Vrel were 0.85 (range, 0.25-2.29) at F10, 0.79 (range, 0.09-2.22) at F20, and 0.78 (range, 0.13-4.27) at 1 month after completion of RT. The median dmigration were 4.7 mm (range, 1.1-20.4 mm) at F10, 4.7 mm (range, 0.8-20.7 mm) at F20, and 6.1 mm (range, 0.0-45.5 mm) at 1 month after completion of RT. Compared with patients who had corpus callosum involvement (n = 26), those without corpus callosum involvement (n = 103) had significant Vrel reduction at F20 (P = .03) and smaller dmigration at F20 (P = .007). Compared with patients who had biopsy alone (n = 19) and subtotal resection (n = 71), those who had gross total resection (n = 38) had significant Vrel reduction at F10 (P = .001) and F20 (P = .001) and a smaller dmigration at F10 (P = .03) and F20 (P = .002). O6-Methylguanine-DNA-methyltransferase methylation and isocitrate dehydrogenase mutation status were not significantly associated with tumor dynamics. The median progression-free survival and overall survival (OS) were 8.5 months (95% CI, 6.9-9.9) and 20.4 months (95% CI, 17.6-25.2). In multivariable analyses, patients with Vrel ≥ 1.33 at F10 had worse OS (hazard ratio [HR], 4.6; 95% CI, 1.8-11.4; P = .001), and patients with dmigration ≥ 5 mm at 1-month post-RT had worse progression-free survival (HR, 1.76; 95% CI, 1.08-2.87) and OS (HR, 2.2; 95% CI, 1.2-4.0; P = .007). CONCLUSIONS: Corpus callosum involvement and extent of surgery are independent predictors of tumor dynamics during RT and can enable patient selection for adaptive RT strategies. Significant tumor enlargement at F10 and tumor migration 1-month post-RT were associated with poorer OS.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ong WL, Stewart J, Sahgal A, et al. Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival. Int J Radiat Oncol Biol Phys. 2024. PMID: 38561051. doi:10.1016/j.ijrobp.2024.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。